NasdaqCM - Delayed Quote USD

Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

0.0576
+0.0004
+(0.70%)
At close: June 12 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
29,414.9500
30,798.8890
39,503.6360
28,228.7580
10,104.5130
Operating Income
-29,414.9500
-30,798.8890
-39,503.6360
-28,228.7580
-10,104.5130
Net Non Operating Interest Income Expense
247.7520
342.8720
364.6880
182.8020
-2.4140
Other Income Expense
266.4950
556.7290
-104.9400
-194.7090
1,591.0550
Pretax Income
-28,900.7030
-29,899.2880
-39,243.8880
-28,240.6650
-8,515.8720
Tax Provision
17.3310
19.5140
16.9490
20.7770
6.0040
Net Income Common Stockholders
-28,918.0340
-29,918.8020
-39,260.8370
-28,261.4420
-8,521.8760
Diluted NI Available to Com Stockholders
-28,918.0340
-29,918.8020
-39,260.8370
-28,261.4420
-8,521.8760
Total Operating Income as Reported
-29,414.9500
-30,798.8890
-39,503.6360
-28,228.7580
-10,104.5130
Total Expenses
29,414.9500
30,798.8890
39,503.6360
28,228.7580
10,104.5130
Net Income from Continuing & Discontinued Operation
-28,918.0340
-29,918.8020
-39,260.8370
-28,261.4420
-8,521.8760
Normalized Income
-29,172.9370
-30,485.7416
-39,071.8564
-28,107.6219
-9,683.3462
Interest Income
274.3820
361.3690
398.4130
182.8020
--
Interest Expense
26.6300
18.4970
33.7250
--
2.4140
Net Interest Income
247.7520
342.8720
364.6880
182.8020
-2.4140
EBIT
-28,874.0730
-29,880.7910
-39,210.1630
-28,228.7580
-8,513.4580
EBITDA
-28,874.0730
-29,880.7910
-39,210.1630
-28,228.7580
-8,513.4580
Reconciled Depreciation
--
--
--
--
0
Net Income from Continuing Operation Net Minority Interest
-28,918.0340
-29,918.8020
-39,260.8370
-28,261.4420
-8,521.8760
Total Unusual Items Excluding Goodwill
322.6620
717.6450
-239.2160
-194.7090
1,591.0550
Total Unusual Items
322.6620
717.6450
-239.2160
-194.7090
1,591.0550
Normalized EBITDA
-29,196.7350
-30,598.4360
-38,970.9470
-28,034.0490
-10,104.5130
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
67.7590
150.7055
-50.2354
-40.8889
429.5848
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ATNFW 180 Life Sciences Corp.
0.0081
0.00%
 
6IRA.F IRLAB Therapeutics AB
0.6330
-0.16%
 
94E.SG Zura Bio Ltd
1.0400
-4.59%
 
94E.F Zura Bio Limited
1.0800
-2.70%
 
BETRF BetterLife Pharma Inc.
0.0660
-4.35%
 
JSPRW Jasper Therapeutics, Inc.
0.1400
0.00%
 
NAMSW NewAmsterdam Pharma Company N.V.
10.07
-0.98%
 
RSPI RespireRx Pharmaceuticals Inc.
0.0017
-5.56%
 
9606.HK Duality Biotherapeutics, Inc.
266.600
-4.79%
 
XBIT XBiotech Inc.
2.7600
-1.78%